Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thymoma × Proton Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Prostatic Neoplasms 12 Brain Neoplasms 11 Sarcoma 6 Meningioma 6 Lung Neoplasms 5 Glioma 5 Pancreatic Neoplasms 4 Glioblastoma 4 Esophageal Neoplasms 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Solid Tumor, Adult 3 Head and Neck Neoplasms 3 Chondrosarcoma 3 Uterine Cervical Neoplasms 2 Thymus Neoplasms 2 Rhabdomyosarcoma 2 Radiation Injuries 2 Pituitary Neoplasms 2 Oligodendroglioma 2 Nerve Sheath Neoplasms 2 Neoplasms 2 Liver Neoplasms 2 Gliosarcoma 2 Ependymoma 2 Chordoma 2 Carcinoma, Intraductal, Noninfiltrating 2 Breast Carcinoma In Situ 2

Interventions

Cyclophosphamide 6 Cisplatin 6 pembrolizumab 5 Sunitinib 5 Radiotherapy 5 Carboplatin 5 Paclitaxel 4 130-nm albumin-bound paclitaxel 3 selinexor 2 Thymectomy 2 Taxes 2 Robotic Surgical Procedures 2 Ramucirumab 2 Prednisone 2 Pemetrexed 2 Octreotide 2 N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide 2 Imatinib Mesylate 2 Etoposide 2 Erlotinib Hydrochloride 2 Doxorubicin 2 Chemoradiotherapy 2 Celecoxib 2 zimberelimab 1 saracatinib 1 regorafenib 1 olaparib 1 lenvatinib 1 isophosphamide mustard 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04822077 2021-03-30

PROTHYM

Swedish Lung Cancer Study Group

Phase NA Recruiting

Thymoma, Thymus Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡